Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Pressurized Metered-dose Inhaler, Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Pressurized Metered-dose Inhaler Product Introduction
  • 1.2 Key Market Segments in This Study
  • 1.3 Key Manufacturers Covered: Ranking of Global Top Pressurized Metered-dose Inhaler Manufacturers by Revenue in 2019
  • 1.4 Market by Type
    • 1.4.1 Global Pressurized Metered-dose Inhaler Market Size Growth Rate by Type
    • 1.4.2 Single-dose Inhalers
    • 1.4.3 Multi-dose Inhalers
  • 1.5 Market by Application
    • 1.5.1 Global Pressurized Metered-dose Inhaler Market Size Growth Rate by Application
    • 1.5.2 Hospitals
    • 1.5.3 Ambulatory Surgery Centres
  • 1.6 Coronavirus Disease 2019 (Covid-19): Pressurized Metered-dose Inhaler Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Pressurized Metered-dose Inhaler Industry
      • 1.6.1.1 Pressurized Metered-dose Inhaler Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Pressurized Metered-dose Inhaler Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Pressurized Metered-dose Inhaler Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Pressurized Metered-dose Inhaler Market Size Estimates and Forecasts
    • 2.1.1 Global Pressurized Metered-dose Inhaler Revenue Estimates and Forecasts 2015-2026
    • 2.1.2 Global Pressurized Metered-dose Inhaler Production Capacity Estimates and Forecasts 2015-2026
    • 2.1.3 Global Pressurized Metered-dose Inhaler Production Estimates and Forecasts 2015-2026
  • 2.2 Global Pressurized Metered-dose Inhaler Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Analysis of Competitive Landscape
    • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 2.3.2 Global Pressurized Metered-dose Inhaler Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.3.3 Global Pressurized Metered-dose Inhaler Manufacturers Geographical Distribution
  • 2.4 Key Trends for Pressurized Metered-dose Inhaler Markets & Products
  • 2.5 Primary Interviews with Key Pressurized Metered-dose Inhaler Players (Opinion Leaders)

3 Market Size by Manufacturers

  • 3.1 Global Top Pressurized Metered-dose Inhaler Manufacturers by Production Capacity
    • 3.1.1 Global Top Pressurized Metered-dose Inhaler Manufacturers by Production Capacity (2015-2020)
    • 3.1.2 Global Top Pressurized Metered-dose Inhaler Manufacturers by Production (2015-2020)
    • 3.1.3 Global Top Pressurized Metered-dose Inhaler Manufacturers Market Share by Production
  • 3.2 Global Top Pressurized Metered-dose Inhaler Manufacturers by Revenue
    • 3.2.1 Global Top Pressurized Metered-dose Inhaler Manufacturers by Revenue (2015-2020)
    • 3.2.2 Global Top Pressurized Metered-dose Inhaler Manufacturers Market Share by Revenue (2015-2020)
    • 3.2.3 Global Top 10 and Top 5 Companies by Pressurized Metered-dose Inhaler Revenue in 2019
  • 3.3 Global Pressurized Metered-dose Inhaler Price by Manufacturers
  • 3.4 Mergers & Acquisitions, Expansion Plans

4 Pressurized Metered-dose Inhaler Production by Regions

  • 4.1 Global Pressurized Metered-dose Inhaler Historic Market Facts & Figures by Regions
    • 4.1.1 Global Top Pressurized Metered-dose Inhaler Regions by Production (2015-2020)
    • 4.1.2 Global Top Pressurized Metered-dose Inhaler Regions by Revenue (2015-2020)
  • 4.2 North America
    • 4.2.1 North America Pressurized Metered-dose Inhaler Production (2015-2020)
    • 4.2.2 North America Pressurized Metered-dose Inhaler Revenue (2015-2020)
    • 4.2.3 Key Players in North America
    • 4.2.4 North America Pressurized Metered-dose Inhaler Import & Export (2015-2020)
  • 4.3 Europe
    • 4.3.1 Europe Pressurized Metered-dose Inhaler Production (2015-2020)
    • 4.3.2 Europe Pressurized Metered-dose Inhaler Revenue (2015-2020)
    • 4.3.3 Key Players in Europe
    • 4.3.4 Europe Pressurized Metered-dose Inhaler Import & Export (2015-2020)
  • 4.4 China
    • 4.4.1 China Pressurized Metered-dose Inhaler Production (2015-2020)
    • 4.4.2 China Pressurized Metered-dose Inhaler Revenue (2015-2020)
    • 4.4.3 Key Players in China
    • 4.4.4 China Pressurized Metered-dose Inhaler Import & Export (2015-2020)
  • 4.5 Japan
    • 4.5.1 Japan Pressurized Metered-dose Inhaler Production (2015-2020)
    • 4.5.2 Japan Pressurized Metered-dose Inhaler Revenue (2015-2020)
    • 4.5.3 Key Players in Japan
    • 4.5.4 Japan Pressurized Metered-dose Inhaler Import & Export (2015-2020)

5 Pressurized Metered-dose Inhaler Consumption by Region

  • 5.1 Global Top Pressurized Metered-dose Inhaler Regions by Consumption
    • 5.1.1 Global Top Pressurized Metered-dose Inhaler Regions by Consumption (2015-2020)
    • 5.1.2 Global Top Pressurized Metered-dose Inhaler Regions Market Share by Consumption (2015-2020)
  • 5.2 North America
    • 5.2.1 North America Pressurized Metered-dose Inhaler Consumption by Application
    • 5.2.2 North America Pressurized Metered-dose Inhaler Consumption by Countries
    • 5.2.3 U.S.
    • 5.2.4 Canada
  • 5.3 Europe
    • 5.3.1 Europe Pressurized Metered-dose Inhaler Consumption by Application
    • 5.3.2 Europe Pressurized Metered-dose Inhaler Consumption by Countries
    • 5.3.3 Germany
    • 5.3.4 France
    • 5.3.5 U.K.
    • 5.3.6 Italy
    • 5.3.7 Russia
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Pressurized Metered-dose Inhaler Consumption by Application
    • 5.4.2 Asia Pacific Pressurized Metered-dose Inhaler Consumption by Regions
    • 5.4.3 China
    • 5.4.4 Japan
    • 5.4.5 South Korea
    • 5.4.6 India
    • 5.4.7 Australia
    • 5.4.8 Taiwan
    • 5.4.9 Indonesia
    • 5.4.10 Thailand
    • 5.4.11 Malaysia
    • 5.4.12 Philippines
    • 5.4.13 Vietnam
  • 5.5 Central & South America
    • 5.5.1 Central & South America Pressurized Metered-dose Inhaler Consumption by Application
    • 5.5.2 Central & South America Pressurized Metered-dose Inhaler Consumption by Country
    • 5.5.3 Mexico
    • 5.5.3 Brazil
    • 5.5.3 Argentina
  • 5.6 Middle East and Africa
    • 5.6.1 Middle East and Africa Pressurized Metered-dose Inhaler Consumption by Application
    • 5.6.2 Middle East and Africa Pressurized Metered-dose Inhaler Consumption by Countries
    • 5.6.3 Turkey
    • 5.6.4 Saudi Arabia
    • 5.6.5 U.A.E

6 Market Size by Type (2015-2026)

  • 6.1 Global Pressurized Metered-dose Inhaler Market Size by Type (2015-2020)
    • 6.1.1 Global Pressurized Metered-dose Inhaler Production by Type (2015-2020)
    • 6.1.2 Global Pressurized Metered-dose Inhaler Revenue by Type (2015-2020)
    • 6.1.3 Pressurized Metered-dose Inhaler Price by Type (2015-2020)
  • 6.2 Global Pressurized Metered-dose Inhaler Market Forecast by Type (2021-2026)
    • 6.2.1 Global Pressurized Metered-dose Inhaler Production Forecast by Type (2021-2026)
    • 6.2.2 Global Pressurized Metered-dose Inhaler Revenue Forecast by Type (2021-2026)
    • 6.2.3 Global Pressurized Metered-dose Inhaler Price Forecast by Type (2021-2026)
  • 6.3 Global Pressurized Metered-dose Inhaler Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

7 Market Size by Application (2015-2026)

  • 7.2.1 Global Pressurized Metered-dose Inhaler Consumption Historic Breakdown by Application (2015-2020)
  • 7.2.2 Global Pressurized Metered-dose Inhaler Consumption Forecast by Application (2021-2026)

8 Corporate Profiles

  • 8.1 Glenmark Pharmaceuticals (India)
    • 8.1.1 Glenmark Pharmaceuticals (India) Corporation Information
    • 8.1.2 Glenmark Pharmaceuticals (India) Overview and Its Total Revenue
    • 8.1.3 Glenmark Pharmaceuticals (India) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.1.4 Glenmark Pharmaceuticals (India) Product Description
    • 8.1.5 Glenmark Pharmaceuticals (India) Recent Development
  • 8.2 Novartis International AG (Switzerland)
    • 8.2.1 Novartis International AG (Switzerland) Corporation Information
    • 8.2.2 Novartis International AG (Switzerland) Overview and Its Total Revenue
    • 8.2.3 Novartis International AG (Switzerland) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.2.4 Novartis International AG (Switzerland) Product Description
    • 8.2.5 Novartis International AG (Switzerland) Recent Development
  • 8.3 Propeller Health (USA)
    • 8.3.1 Propeller Health (USA) Corporation Information
    • 8.3.2 Propeller Health (USA) Overview and Its Total Revenue
    • 8.3.3 Propeller Health (USA) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.3.4 Propeller Health (USA) Product Description
    • 8.3.5 Propeller Health (USA) Recent Development
  • 8.4 AstraZeneca Plc (Sweden)
    • 8.4.1 AstraZeneca Plc (Sweden) Corporation Information
    • 8.4.2 AstraZeneca Plc (Sweden) Overview and Its Total Revenue
    • 8.4.3 AstraZeneca Plc (Sweden) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.4.4 AstraZeneca Plc (Sweden) Product Description
    • 8.4.5 AstraZeneca Plc (Sweden) Recent Development
  • 8.5 Philips Respironics (Netherlands)
    • 8.5.1 Philips Respironics (Netherlands) Corporation Information
    • 8.5.2 Philips Respironics (Netherlands) Overview and Its Total Revenue
    • 8.5.3 Philips Respironics (Netherlands) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.5.4 Philips Respironics (Netherlands) Product Description
    • 8.5.5 Philips Respironics (Netherlands) Recent Development
  • 8.6 Teva Pharmaceutical Industries （Israel）
    • 8.6.1 Teva Pharmaceutical Industries （Israel） Corporation Information
    • 8.6.2 Teva Pharmaceutical Industries （Israel） Overview and Its Total Revenue
    • 8.6.3 Teva Pharmaceutical Industries （Israel） Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.6.4 Teva Pharmaceutical Industries （Israel） Product Description
    • 8.6.5 Teva Pharmaceutical Industries （Israel） Recent Development
  • 8.7 Opko Health (USA)
    • 8.7.1 Opko Health (USA) Corporation Information
    • 8.7.2 Opko Health (USA) Overview and Its Total Revenue
    • 8.7.3 Opko Health (USA) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.7.4 Opko Health (USA) Product Description
    • 8.7.5 Opko Health (USA) Recent Development
  • 8.8 Merck (USA)
    • 8.8.1 Merck (USA) Corporation Information
    • 8.8.2 Merck (USA) Overview and Its Total Revenue
    • 8.8.3 Merck (USA) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.8.4 Merck (USA) Product Description
    • 8.8.5 Merck (USA) Recent Development
  • 8.9 BioCare Group （Malaysia）
    • 8.9.1 BioCare Group （Malaysia） Corporation Information
    • 8.9.2 BioCare Group （Malaysia） Overview and Its Total Revenue
    • 8.9.3 BioCare Group （Malaysia） Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.9.4 BioCare Group （Malaysia） Product Description
    • 8.9.5 BioCare Group （Malaysia） Recent Development

9 Production Forecasts by Regions

  • 9.1 Global Top Pressurized Metered-dose Inhaler Regions Forecast by Revenue (2021-2026)
  • 9.2 Global Top Pressurized Metered-dose Inhaler Regions Forecast by Production (2021-2026)
  • 9.3 Key Pressurized Metered-dose Inhaler Production Regions Forecast
    • 9.3.1 North America
    • 9.3.2 Europe
    • 9.3.3 China
    • 9.3.4 Japan

10 Pressurized Metered-dose Inhaler Consumption Forecast by Region

  • 10.1 Global Pressurized Metered-dose Inhaler Consumption Forecast by Region (2021-2026)
  • 10.2 North America Pressurized Metered-dose Inhaler Consumption Forecast by Region (2021-2026)
  • 10.3 Europe Pressurized Metered-dose Inhaler Consumption Forecast by Region (2021-2026)
  • 10.4 Asia Pacific Pressurized Metered-dose Inhaler Consumption Forecast by Region (2021-2026)
  • 10.5 Latin America Pressurized Metered-dose Inhaler Consumption Forecast by Region (2021-2026)
  • 10.6 Middle East and Africa Pressurized Metered-dose Inhaler Consumption Forecast by Region (2021-2026)

11 Value Chain and Sales Channels Analysis

  • 11.1 Value Chain Analysis
  • 11.2 Sales Channels Analysis
    • 11.2.1 Pressurized Metered-dose Inhaler Sales Channels
    • 11.2.2 Pressurized Metered-dose Inhaler Distributors
  • 11.3 Pressurized Metered-dose Inhaler Customers

12 Market Opportunities & Challenges, Risks and Influences Factors Analysis

  • 12.1 Market Opportunities and Drivers
  • 12.2 Market Challenges
  • 12.3 Market Risks/Restraints
  • 12.4 Porter's Five Forces Analysis

13 Key Finding in The Global Pressurized Metered-dose Inhaler Study

    14 Appendix

    • 14.1 Research Methodology
      • 14.1.1 Methodology/Research Approach
      • 14.1.2 Data Source
    • 14.2 Author Details

    Pressurized Metered-dose Inhaler market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pressurized Metered-dose Inhaler market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Pressurized Metered-dose Inhaler market is segmented into
    Single-dose Inhalers
    Multi-dose Inhalers

    Segment by Application, the Pressurized Metered-dose Inhaler market is segmented into
    Hospitals
    Ambulatory Surgery Centres

    Regional and Country-level Analysis
    The Pressurized Metered-dose Inhaler market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Pressurized Metered-dose Inhaler market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
    Competitive Landscape and Pressurized Metered-dose Inhaler Market Share Analysis

    Pressurized Metered-dose Inhaler market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Pressurized Metered-dose Inhaler by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Pressurized Metered-dose Inhaler business, the date to enter into the Pressurized Metered-dose Inhaler market, Pressurized Metered-dose Inhaler product introduction, recent developments, etc.
    The major vendors covered:
    Glenmark Pharmaceuticals (India)
    Novartis International AG (Switzerland)
    Propeller Health (USA)
    AstraZeneca Plc (Sweden)
    Philips Respironics (Netherlands)
    Teva Pharmaceutical Industries （Israel）
    Opko Health (USA)
    Merck (USA)

    Buy now